She has made many significant contributions to vascular biology and hypertension research. Advisor/Consultant: BackBeat Medical; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Eli Lilly; Forest Laboratories; Medtronic; Merck; NicOx; Novartis;Omron Healthcare; Pfizer Grant/Research Support: Daiichi Sankyo; Merck; Novartis; Takeda Vlado Perkovic, MBBS, FRACP, FASN, PhD, is Executive Director, George Clinical at The George Institute for International Health and Staff Specialist in Nephrology and Hypertension at the Royal North Shore and Sydney Adventist Hospitals. Dr Perkovic received his medical and doctorate degrees from University of Melbourne and completed his training in nephrology and general medicine at the Royal Melbourne Hospital. His research interests include elucidat- ing the roles of BP and lipid management and their impact on CVD in CKD patients. In this vein, Dr Perkovic is a committee member of the ALTITUDE and SHARP trials and an organizer of the Cardiovascular Guideline Group for Caring for Australasians with Renal Impairment (CARI). As an author of over 75 publications, Dr Perkovic also serves as a peer reviewer to numerous journals and a grant reviewer for the National Health and Medical Research Council. Advisor/Consultant: Abbott; Baxter; Boehringer Ingelheim; Johnson & Johnson; Vitae Honoraria: AstraZeneca; Roche; Servier Grant/Research Support: Baxter; Johnson & Johnson Cibele Isaac Saad Rodrigues, MD, PhD, is a full Professor of Nephrology at the Faculdade de Cie ncias Me dicas e da Sau de Pontif cia Universidade Cato lica de Sa o Paulo (PUC-SP), Brazil where she also graduated and completed her Residency in Internal Medicine and Nephrology. She obtained her master s and doctorate degrees in Nephrology at the Federal University of Sa o Paulo, Brazil. 